A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
Early last year we reported1 on a study by Wakefield and colleagues which suggested there may be an association between measles containing vaccine, inflammatory bowel disease (IBD) and autism.2 The evidence for either association was very weak1 and the study was conducted on a highly selected group of subjects. Since then several epidemiological investigations have found no evidence for any association with autism and/or IBD.5,6,7,8,9 Also, specific virological assays in patients with IBD, the proposed aetiological link for autism after measles-mumps-rubella (MMR) vaccination, have not detected measles virus.3,4 Following the publication of the Wakefield study2 however, there has been a measurable decrease in the uptake of MMR in the United Kingdom (UK).10
In June this year two further reports were published that provide no support for a causal link between measles vaccine and autism.11,12 The Working Party on MMR Vaccine of the UK's Committee on Safety of Medicine's study11 evaluated the reports of autism, Crohn's disease, and similar disorders developing after MMR or MR vaccination, collected by a firm of solicitors. A systematic review of these cases lead the Working Party to conclude that the information available (which was of variable quality, subject to selection bias and lacked a control group) did not support the suggested causal association between measles vaccine and autism or Crohn's disease.
The second report, by Taylor et al.,12 is a population-based study that overcomes many of the limitations of the Working Party's study. Taylor's study investigated 498 children with autism born since 1979 in the North Thames Region. These children's measles vaccination status was determined from an independent register. The investigators found that:
- there was a steady increase in cases of autism over time, however there was no 'step-up' after the introduction of MMR in 1988;
- the age of diagnosis of children with autism was not dependent on when or if a child had been vaccinated;
- vaccination coverage rates in cases did not differ significantly from that for the region as a whole; and
- developmental regression was not clustered in the months after vaccination.
Top of page
References1. Amin J, McIntyre PB, Heath TC. Measles vaccine, inflammatory bowel disease and pervasive developmental disorder: is there cause for concern? Commun Dis Intell 1998;22:8-59.
2. Wakefield AJ, Murch SH, Anthony A et al. Ileal-lymphoid- nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998;351:637-41.
3. Afzal MA, Minor PD, Begley J et al. Absence of measles-virus genome in inflammatory bowel disease. Lancet 1998;351:646-647.
4. Chadwick N, Bruce IJ, Schpelmann S, Pounder RE, Wakefield AJ. Measles virus DNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcriptase followed by polymerase chain reaction. J Med Virol 1998;55:305-311.
5. Gillberg C, Steffenburg S, Schaumann H. Is autism more common now than 10 years ago. Br J Psychiatry 1998;158:403-409.
6. Wing L. Autism spectrum disorders: no evidence for or against an increase in prevalence. BMJ 1996;312:327-328.
7. Payne C, Mason B. Autism, inflammatory bowel disease, and MMR vaccine. Lancet 1998;351:907.
8. Fombonne E. Inflammatory bowel disease and autism. Lancet 1998;351:955.
9. Peltola H, Patja A, Leinikki P Valle M, Davidkin I, Paunio M. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 1998;351:1327-1328.
10. CDSC COVER/Korner: April to June 1998 Commun Dis Rep CDR Wkly 1998;8:345-346.
11. Medicines Commission Agency/Committee on Safety of Medicines. The safety of MMR vaccine. Curr Probl Pharmacovigilance 1999:25:9-10.
12. Taylor B, Miller E, Farrington CP et al. Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a casual association. Lancet 1999:353 (9169):2026-29.
The NCIRS was established by the National Centre for Disease Control, Commonwealth Department of Health and Aged Care. The Centre analyses, interprets, and evaluates national surveillance data on immunisation coverage and vaccine preventable diseases. NCIRS also identifies research priorities, and initiates and coordinates research on immunisation issues and the epidemiology of vaccine preventable diseases in Australia
This article was published in Communicable Diseases Intelligence Volume 23, No 8, 5 August 1999.